
GSK and Fleming Initiative launch programmes to tackle AMR
GSK and the Fleming Initiative have launched six major new research programmes aiming to combat antimicrobial resistance (AMR). The six ‘Grand Challenges’ will bring together scientific expertise and the latest technologies, including AI, to find new ways to slow the progress of AMR. The project has been backed by… Read More















